Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia.

Pediatric blood & cancer - 1 Jan 2021

Langenberg-Ververgaert Karin, Renzi Samuele, Fuligni Fabio, Davidson Scott, Abdelhaleem Mohamed, Lo Winnie, Malkin David, Shlien Adam, Shago Mary, Villani Anita, Abla Oussama

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Fatal Outcome
Share to Leukemia, Megakaryoblastic, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogene Proteins, Fusion

Share to Promoter Regions, Genetic

Share to RNA-Binding Proteins

Share to Telomerase

Share to Trans-Activators

Source

Identifiers

PMID: 32743872
DOI: 10.1002/pbc.28542

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia.PMID 32743872Read ↗

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.Semantic proximity Read ↗

Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Semantic proximity Read ↗

The protective role of MTR A2756G polymorphisms in childhood acute lymphoblastic leukemia remains inconclusive.Semantic proximity Read ↗

Evaluation of 17 genetic variants in association with leukemia in the north Indian population using MassARRAY Sequenom.Semantic proximity Read ↗

Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML).Semantic proximity Read ↗

Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.Semantic proximity Read ↗

The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies.Semantic proximity Read ↗

WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups.Semantic proximity Read ↗

Acute myeloid leukaemia in a case with Tatton-Brown-Rahman syndrome: the peculiar DNMT3A R882 mutation.Semantic proximity Read ↗

WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.Semantic proximity Read ↗

RBM10: Harmful or helpful-many factors to consider.Semantic proximity Read ↗

WT1 mutations and single nucleotide polymorphism rs16754 analysis of patients with pediatric acute myeloid leukemia in a Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.